The Diabetes Research Group at Swansea University have collaborated with clinical staff and Eli Lilly to design a self-management learning Web App. Due to the COVID-19 pandemic, virtual consultations whether by telephone or video are increasingly common meaning the diabetes team cannot physically examine people with diabetes. Therefore, the aim of the app is to support people living with diabetes to perform self-examinations for monitoring or in preparation for a review with their usual diabetes health care provider (HCP). It is hoped the app will help aid conversations between people with diabetes and the diabetes HCP virtually.
This new development starts with the ‘Lipo checker’. It provides a step-by-step guide on how to perform an accurate examination of injection sites to detect for the presence of lipotrophy (including lipohypertrophy and lipoatrophy), and to learn about the causes and how to prevent ‘Lipos’ occurring.
The App can be used on any device via the browser and also saved on mobile devices. To access, scan the QR code below or visit https://sumsapps.github.io/cli...
The App includes links to resources that can help people avoid ‘Lipos’. The scientific evidence section summaries how ‘Lipos’ can de-stabilise blood glucose management, and how common this problem is for people using insulin injections for their diabetes treatment.